BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 25159681)

  • 1. Personalizing risk stratification by addition of PAK1 expression to TNM staging: improving the accuracy of clinical decision for gastroesophageal junction adenocarcinoma.
    Li Z; Zou X; Xie L; Chen H; Chen Y; Yeung SC; Zhang H
    Int J Cancer; 2015 Apr; 136(7):1636-45. PubMed ID: 25159681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic importance and therapeutic implications of PAK1, a drugable protein kinase, in gastroesophageal junction adenocarcinoma.
    Li Z; Zou X; Xie L; Dong H; Chen Y; Liu Q; Wu X; Zhou D; Tan D; Zhang H
    PLoS One; 2013; 8(11):e80665. PubMed ID: 24236193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognostic value of metastatic lymph node ratio in adenocarcinoma of the gastroesophageal junction].
    Zhang HD; Ma Z; Tang P; Duan XF; Ren P; Yue J; Yu ZT
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Sep; 16(9):822-6. PubMed ID: 24061985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of number of metastatic lymph nodes and metastatic lymph node ratio on the prognosis in patients with adenocarcinoma of the esophagogastric junction after curative resection].
    Zhang H; Chen C; Yue J; Ma M; Ma Z; Yu Z
    Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):141-6. PubMed ID: 24796465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extranodal metastasis is a powerful prognostic factor in patients with adenocarcinoma of the esophagogastric junction.
    Zhang HD; Tang P; Duan XF; Chen CG; Ma Z; Gao YY; Zhang H; Yu ZT
    J Surg Oncol; 2013 Dec; 108(8):542-9. PubMed ID: 24018956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymph node metastases of adenocarcinoma of the esophagus and esophagogastric junction.
    Zhang X; Watson DI; Jamieson GG
    Chin Med J (Engl); 2007 Dec; 120(24):2268-70. PubMed ID: 18167216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Circulating Tumor DNA and Clinical Correlates in Patients with Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma.
    Kato S; Okamura R; Baumgartner JM; Patel H; Leichman L; Kelly K; Sicklick JK; Fanta PT; Lippman SM; Kurzrock R
    Clin Cancer Res; 2018 Dec; 24(24):6248-6256. PubMed ID: 30348637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can extracapsular lymph node involvement be a tool to fine-tune pN1 for adenocarcinoma of the oesophagus and gastro-oesophageal junction in the Union Internationale contre le Cancer (UICC) TNM 7th edition?†.
    Nafteux P; Lerut T; De Hertogh G; Moons J; Coosemans W; Decker G; Van Veer H; De Leyn P
    Eur J Cardiothorac Surg; 2014 Jun; 45(6):1001-10. PubMed ID: 24477743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphangiogenesis and prognostic significance of vascular endothelial growth factor C in gastro-oesophageal junction adenocarcinoma.
    Xie LX; Zhai TT; Yang LP; Yang E; Zhang XH; Chen JY; Zhang H
    Int J Exp Pathol; 2013 Feb; 94(1):39-46. PubMed ID: 23317352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nodal staging in adenocarcinoma of the gastro-esophageal junction. Proposal of a specific staging system.
    Pedrazzani C; deManzoni G; Marrelli D; Giacopuzzi S; Corso G; Bernini M; Roviello F
    Ann Surg Oncol; 2007 Feb; 14(2):299-305. PubMed ID: 17146743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Staging of adenocarcinoma of the gastroesophageal junction.
    Parry K; Haverkamp L; Bruijnen RC; Siersema PD; Offerhaus GJ; Ruurda JP; van Hillegersberg R
    Eur J Surg Oncol; 2016 Mar; 42(3):400-6. PubMed ID: 26777127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymph node involvement in advanced gastroesophageal junction adenocarcinoma.
    Pedrazzani C; de Manzoni G; Marrelli D; Giacopuzzi S; Corso G; Minicozzi AM; Rampone B; Roviello F
    J Thorac Cardiovasc Surg; 2007 Aug; 134(2):378-85. PubMed ID: 17662776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of number and site of lymph node invasion on survival of adenocarcinoma of esophagogastric junction.
    Ielpo B; Pernaute AS; Elia S; Buonomo OC; Valladares LD; Aguirre EP; Petrella G; Garcia AT
    Interact Cardiovasc Thorac Surg; 2010 May; 10(5):704-8. PubMed ID: 20154347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbohydrate antigen 19-9 is a useful prognostic marker in esophagogastric junction adenocarcinoma.
    Tokunaga R; Imamura Y; Nakamura K; Uchihara T; Ishimoto T; Nakagawa S; Iwatsuki M; Baba Y; Sakamoto Y; Miyamoto Y; Yoshida N; Oyama S; Shono T; Naoe H; Saeki H; Oki E; Watanabe M; Sasaki Y; Maehara Y; Baba H
    Cancer Med; 2015 Nov; 4(11):1659-66. PubMed ID: 26310928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological features and prognostic factors of adenocarcinoma of the esophagogastric junction according to Siewert classification: experiences at a single institution in Japan.
    Hosokawa Y; Kinoshita T; Konishi M; Takahashi S; Gotohda N; Kato Y; Daiko H; Nishimura M; Katsumata K; Sugiyama Y; Kinoshita T
    Ann Surg Oncol; 2012 Feb; 19(2):677-83. PubMed ID: 21822549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of old and new TNM systems for nodal staging in adenocarcinoma of the gastro-oesophageal junction.
    de Manzoni G; Pedrazzani C; Verlato G; Roviello F; Pasini F; Pugliese R; Cordiano C
    Br J Surg; 2004 Mar; 91(3):296-303. PubMed ID: 14991629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Explored Risk Factors for Lymph Node Metastasis with Siewert II/III Adenocarcinoma of the Gastroesophageal Junction.
    Zheng Z; Yin J; Wu HW; Li J; Cai J; Qin SQ; Zhang J; Yao HW; Li JS; Zhang ZT
    Anticancer Res; 2017 Aug; 37(8):4605-4610. PubMed ID: 28739759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Siewert III esophagogastric junction adenocarcinoma: does TNM 8th save us?
    Zanoni A; Verlato G; Baiocchi GL; Casella F; Cossu A; d'Ignazio A; De Pascale S; Giacopuzzi S
    Updates Surg; 2018 Jun; 70(2):241-249. PubMed ID: 29808375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nomogram predicted survival of patients with adenocarcinoma of esophagogastric junction.
    Zhou Z; Zhang H; Xu Z; Li W; Dang C; Song Y
    World J Surg Oncol; 2015 Jun; 13():197. PubMed ID: 26055624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival in Patients With Esophageal Adenocarcinoma Undergoing Trimodality Therapy Is Independent of Regional Lymph Node Location.
    Sepesi B; Schmidt HE; Lada M; Correa AM; Walsh GL; Mehran RJ; Rice DC; Roth JA; Vaporciyan AA; Ajani JA; Watson TJ; Swisher SG; Low DE; Hofstetter WL
    Ann Thorac Surg; 2016 Mar; 101(3):1075-80; Discussion 1080-1. PubMed ID: 26680311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.